BALTIMORE, Nov. 14, 2017 – Elixirgen Scientific’s new vascular endothelial cell differentiation kit will accelerate mini-organ projects including 3D bioprinting and tissue chips. The Baltimore biotech company today released Quick-Endothelial™ Vascular, a lab kit using synthetic mRNA that will help scientists create vascular endothelial cells in only one week. Vascular endothelial cells are also available through Elixirgen Scientific’s cell differentiation services.
There are currently no options in the market for researchers to differentiate human pluripotent stem cells (hPSCs) into vascular endothelial cells except by attempting to replicate publications. Researchers can now easily grow the same hPSC-derived vascular endothelial cells to co-culture or mix with other hPSC derived tissues such as neurons, hepatocytes, and cardiomyocytes to develop mini-organs like the brain, liver, and heart. Elixirgen Scientific expects strong demand from researchers in 3D bioprinting and tissue chips.